SPOTLIGHT -
Optum Perks Introduces New Telehealth Solution
Offerings include treatment plans for a considerable number of illnesses and conditions, company says.
FDA Grants Clearance to Clinical Trial for NK CellTech’s Non-Genetically Modified Natural Killer Cells
NK010 is reportedly the first Chinese trial of its kind to be approved by the FDA.
Opdivo Plus Yervoy Reduces the Risk of Colorectal Cancer Disease Progression or Death by 79% Versus Chemotherapy
Opdivo plus Yervoy shows promise in treating patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer.
CARsgen Reveals Updated Satri-Cel Research Updates at ASCO GI 2024
Study reportedly demonstrates the encouraging safety profile of satri-cel, the first autologous Claudin18.2 CAR T cell therapy.
Bloomlife’s Maternal and Fetal Monitoring Device Receives FDA Approval
Bloomlife’s MFM-Pro is a prescription-based wearable device that can track the maternal and fetal heart rate.
Poll Reveals Only a Small Number of Older Americans Have Used Online Direct-to-Consumer Health Services
Researchers believe low numbers in the use of direct-to-consumer healthcare services could rapidly trend up.
Arcutis’ Zoryve Shows Progress for Individuals with Atopic, Seborrheic Dermatitis
Company displayed findings at the 2024 Winter Clinical Dermatology Conference in Hawaii demonstrating significant improvements in atopic dermatitis and seborrheic dermatitis.
Report: Pharmaceutical Contract Manufacturing Market Expected to Hit $140 Billion by 2030
Roots Analysis report suggests increase can be attributed to the growing demand for advanced therapies and biologics.
AstraZeneca Vice President, Head of Breast Cancer Franchise, Discusses Impact of Truqap Approval
In an interview with Pharmaceutical Executive associate editor Don Tracy, Ashley Gaines, VP, head of breast cancer franchise, discusses newly approved Truqap.
Examining the Prevalence of Underinsurance in Children with Special Health Care Needs
JAMA study investigates whether physical or behavioral healthcare needs are associated with the risk of underinsurance across household income levels.
Lilly Pens Open Letter Raising Concerns Regarding Use of Mounjaro for Cosmetic Weight Loss
Company cites potential safety risks for patients who ignore the intended indication of Mounjaro and Zepbound.
Reviewing the Accuracy of AI Provided Health Information
JAMA study evaluates the ability of artificial intelligence to transform electronic health.
The Transformative Potential of AI and Machine Learning in Biomedical Research and Healthcare
Oxford Academic report explores the positive improvements these technological capabilities could bring to the industry.
Survey: 79% of Respondents Admit to Neglecting Health Needs During the Holiday Season
American Heart Association survey suggests holiday stress has a major impact on health habits.
Study Finds Association Between Neighborhood-Level Socioeconomic Status, Medication Nonadherence Among Heart Failure Patients
JAMA study aims to discover whether ignoring medical advice relates to financial status among patients with heart failure.
Study Highlights Need for Pharma Industry to Address Stigmatization of Acne
JAMA Network study evaluates current attitudes toward individuals with acne with a call for pharma companies to focus efforts on helping to overcome these stigmas.
Report: Experimental HIV Vaccine Unlikely to be Effective in Preventing Acquisition
PREPVACC study expected to stop further HIV vaccination attempts after previously enrolling 1,500 participants in East and Southern Africa.
Q&A With UCB's Camille Lee on the Bimzelx Navigate Patient Support System
Camille Lee explains the ins and outs of the patient support system for psoriasis medication.
Q&A With UCB's Camille Lee on New Psoriasis Medication Approval
UCB executive speaks on recent FDA approval of Bimzelx.
Reviewing the FDA’s Regulatory Approach to Dietary Supplements
National Library of Medicine study emphasizes inadequacies in ensuring the safety and efficacy of over-the-counter dietary supplements.
Top Health Trends On the Horizon in 2024
An overview of the nine biggest developments to expect across the healthcare industry in the year ahead.
Reviewing Consistency and Adequacy of Public vs. Commercial Health Insurance for American Children
JAMA study evaluates differences in coverage types and potential from 2016-2021.
GSK Survey Discovers Extensive Misconceptions About Shingles
Findings show that a considerable number of adults remain uneducated on how herpes zoster is triggered.
Phase 3 Trial for GSK’s Blenrep Yields Positive Results in Relapsed or Refractory Multiple Myeloma
Blenrep significantly extended the time to disease progression or death against existing care methods as a second-line treatment for relapsed or refractory multiple myeloma.
Research Explores Adverse Outcomes From Energy Drink Intake Before, During Pregnancy
JAMA study investigates whether consuming energy drinks was associated with adverse pregnancy outcomes and whether caffeine consumption affects fetal-growth restriction.
Citing Ongoing Drug Shortages, Biden Administration Invokes Defense Production Act
Law aims to mitigate ongoing global drug shortages.
Phase 3 Clinical Trial for Dupixent Reports Significant Reduced COPD Exacerbations
Trial results expected to accelerate the potential of Dupixent to become the first FDA-approved treatment for chronic obstructive pulmonary disease.
Investigating Industry Involvement in Modern Clinical Trials
Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are.
Phase 3 Study for AbbVie’s Ubrelvy Reports Promising Results
Medication focuses on the acute treatment of migraines.
The Importance of the Medical Affairs Function in Pharmaceutical Companies
Study emphasizes role in bridging research and development and commercial/marketing functions.